MOUNTAIN VIEW, Calif., May 14 /PRNewswire-FirstCall/ -- Omnicell, Inc. , a leading provider of patient safety technology, announced today that it intends to offer to sell, subject to market and other conditions, 3,900,000 shares of its common stock pursuant to an effective registration statement previously filed with the Securities and Exchange Commission. In connection with this offering, the Company intends to grant the underwriters a 30-day option to purchase up to an additional 585,000 shares of its common stock. All of the shares are being offered by the Company.
The underwriters of this offering will be Merrill Lynch & Co., acting as sole book-running manager, with Piper Jaffray & Co., First Albany Capital Inc. and Caris & Company, Inc. acting as co-managers. This communication shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Copies of the prospectus and prospectus supplement may be obtained from Merrill Lynch & Co., at 4 World Financial Center, New York, NY, 10080, 212-449-1000.
About Omnicell
Omnicell, Inc. is a leading provider of systems and software solutions targeting patient safety and operational efficiency in healthcare facilities. Since 1992, Omnicell has worked to enhance patient safety and allow clinicians to spend more time with their patients.
Omnicell's medication-use product line includes solutions for the central pharmacy, nursing unit, operating room, and patient bedside. Solutions range from large central pharmacy "smart inventory carousels to small handheld devices. From the point at which a medication arrives at the receiving dock to the time it is administered, Omnicell systems store it, package it, bar code it, order it, issue it, and provide information and controls on its use and reorder.
Our supply product lines provide a healthcare institution with fast, effective control of costs, capture of charges for payer reimbursement, and timely reorder of supplies. Products range from high-security closed-cabinet systems and software to open-shelf and combination solutions in the nursing unit, catheter lab and operating room.
Omnicell's mission is to provide the best customer experience in healthcare, helping hospitals reduce medication errors, operate more efficiently, and decrease costs. For more information, visit www.omnicell.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements about our proposed offering of shares of our common stock. These statements involve certain risks and uncertainties, including those discussed in our Registration Statement on Form S-3 filed with the Securities and Exchange Commission on May 14, 2007, our Annual Report on Form 10-K for the year ended December 31, 2006 and in other reports filed by Omnicell, Inc. with the Securities and Exchange Commission. Because these statements reflect our current expectations concerning future events, our actual results could differ materially from those anticipated in these forward-looking statements as a result of many factors. These factors include, but are not limited to, market conditions and other conditions to closing of the proposed offering. We are providing this information as of May 14, 2007. Omnicell undertakes no duty to update any forward-looking statements to reflect the occurrence of events or circumstances after the date of such statements or of anticipated or unanticipated events that alter any assumptions underlying such statements.
Omnicell, Inc.CONTACT: Bruce Lewis of Lewis & Summers Public Relations, +1-707-964-3844,bruce@prwebsite.com, for Omnicell, Inc.
Web site: http://www.omnicell.com//
